0000899243-21-034986.txt : 20210902
0000899243-21-034986.hdr.sgml : 20210902
20210902200029
ACCESSION NUMBER: 0000899243-21-034986
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210901
FILED AS OF DATE: 20210902
DATE AS OF CHANGE: 20210902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krehlik Carrie
CENTRAL INDEX KEY: 0001823899
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 211234846
MAIL ADDRESS:
STREET 1: 6015 COLTON BLVD
CITY: OAKLAND
STATE: CA
ZIP: 94611
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-01
0
0001629137
Global Blood Therapeutics, Inc.
GBT
0001823899
Krehlik Carrie
C/O GLOBAL BLOOD THERAPEUTICS, INC.
181 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Human Resources Officer
Restricted Stock Units
2021-09-01
4
A
0
32240
0.00
A
Common Stock
32240
32240
D
Restricted Stock Units
2021-09-01
4
A
0
42400
0.00
A
Common Stock
42400
42400
D
Stock Option (Right to Buy)
29.85
2021-09-01
4
A
0
49600
0.00
A
2031-08-31
Common Stock
49600
49600
D
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
The RSUs vest with respect to 25% of the underlying shares on September 1, 2022 and in six semi-annual installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
The RSUs vest in installments conditioned upon the achievement, on or before June 30, 2024, of up to three specified market price thresholds of the Issuer, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
The stock option vests with respect to 25% of the underlying shares on August 2, 2022 and in 12 equal quarterly installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
/s/ Miguel Carrillo, as Attorney-in-Fact
2021-09-02